FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, ...

A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway found a 45% lower risk in ...

GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric ...

Ozempic may lower dementia and nicotine dependence risk in people with type 2 diabetes. ... Ozempic May Reduce Need for Insulin in New Type 1 Diabetes Patients Published on September 8, 2023.

Ozempic use is associated with a lowered risk for cognitive problems, researchers in a new study said. The findings, however, cannot be applied to users who do not have diabetes. The study ...

Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro may slash the risk of a disorder affecting nearly 7million ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Ozempic use is associated with a lowered risk for cognitive problems, researchers in a new study said. ... Ozempic may reduce dementia: Research by Eden Teshome - 07/12/24 1:23 PM ET.

An analysis of over 100,000 medical records found that Ozempic users had a far lower dementia risk than those that took other diabetes drugs.

The study found Ozempic, ... The findings also suggest that treatment with semaglutide and similar drugs may be associated with a lower risk of dementia and can help reduce nicotine cravings.

New research suggests that the diabetes drug and popular weight loss treatment semaglutide, commonly known as Ozempic and Wegovy, is linked with a lower risk of dementia — possibly adding to the ...

Researchers found that semaglutide, known as Ozempic/ Wegovy, does not increase the risk of neurological or psychiatric conditions compared to other antidiabetic drugs. It may also reduce the risk of ...